期刊文献+

HBsAg阳性孕妇血清HBV—DNA含量与胎儿宫内感染关系探讨 被引量:4

Correlative Study on Serum Hepatitis B Virus DNA Level of Gravidas with Mother-to-Infant Transmission
下载PDF
导出
摘要 目的探讨孕妇血清HBV-DNA含量与母婴宫内传播的相关性。方法选择住院分娩的HBsAg阳性孕妇,使用荧光定量PCR方法检测孕妇及其新生儿脐血血清中HBV-DNA含量以及乙肝病毒血清标志物。结果新生儿脐带血的HBv.DNA阳性率为18.5%(17/92),高于脐带血HBsAg的阳性率5.4%(5/92)(P〈0.01);血清HBeAg阳性孕妇其新生儿脐带血HBV-DNA阳性率为41.2%(14/34),高于HBeAg阴性孕妇组的阳性率5.2%(3/58)(P〈0.01);且胎儿宫内感染率随母亲血清HBV-DNA含量的增加而升高,HBV-DNA含量与胎儿宫内感染率呈正相关(r=9.439,R=0.46,Pd0.01)。结论应用荧光定量聚合酶链反应检测新生儿脐带血HBV-DNA是监测乙型肝炎发生宫内传播的较敏感指标;孕妇血清HBV-DNA高含量是乙型肝炎宫内感染的主要因素之一。 Objective To investigate the relationship between serum hepatitis B virus DNA (HBV-DNA) level of gravida and mother-to-infant transmission. Methods HBV-DNA were quantitatively examined by FQ-PCR in 92 pregnant women detec- ted positive for HBV and their newborns,and serologic HBV markers were detected by enzyme linked immunoadsorbent assay (ELISA). Results HBV-DNA positive rate of infant umbilical cord blood was 18. 5% (17/92) ,which was significantly higher than HBsAg positive rate 5.4% (5/92) (P〈0. 01). HBV-DNA positive rate of newborns born to HBeAg (+) motherwas 41.2% (14/34), which was significantly higher than those born to HBeAg(-) mother 5. 2% (3/58)(P〈 0.01);HBV-DNA and intrauterine fetal infection rates were positively correlated. Conclusion Using FQ-PCR to detect HBV-DNA of umbilical cord blood in newborn infants is a sensitive screenmethod inmonitoring intrauterine HBV transmission. High level of HBV-DNA in pregnantwomen is one of the high risk factors of intrauterine HBV transmission and infection.
作者 唐芳玫
出处 《现代检验医学杂志》 CAS 2012年第4期139-141,共3页 Journal of Modern Laboratory Medicine
关键词 乙型肝炎病毒 HBV-DNA聚合酶连反应 宫内感染 hepatitis B virus HBV-DNA polymerase chain reaction intrauterine infection
  • 相关文献

参考文献5

二级参考文献14

共引文献120

同被引文献49

  • 1李萍,刘晓蓉,程薇,王涛,周新娥.长疗程大剂量乙肝免疫球蛋白阻断乙肝病毒宫内传播的研究[J].实用医院临床杂志,2010,7(4):30-32. 被引量:2
  • 2温旺荣,苏芳,吴勇,曹燕.乳汁处理方法对检测HBV DNA结果的影响[J].临床检验杂志,2007,25(1):31-31. 被引量:13
  • 3王小兰,胡美霞,周世琼.荧光定量PCR检测母脐血HBV-DNA与母婴传播的临床研究[J].中国妇幼保健,2007,22(12):1684-1685. 被引量:5
  • 4Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination [ J ]. Vaccine, 2009,27 (47) : 6550 - 6657.
  • 5Ni YH, Chang MH, Wu JF, et al. Minimization of hepatitis B infection by a 25-year universal vaccination program [J]. J Hepatol,2012,57(4) :730-735.
  • 6Ang LW,Tey SH, Cutter J, et al. Seroprevalence of hepati- tis B virus infection among children and adolescents in Singapore,2008-2010 [ J ]. J Med Virol, 2013,85 (4) :583- 588.
  • 7Tse K, Siu SL, Yip KT, et al. Imuno-prophylaxis of babies borne to hepatitis B carrier mothers [ J ]. Hong Kong Med J,2006,12(5) :368-374.
  • 8Yin Y, Wu L, Zhang J, et al. Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virus [ J ]. J Infect, 2013,66(5 ) :447-452.
  • 9Oon CJiLim GK, Ye Z, et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore [ J ]. Vac-cine, 1995,13 ( 8 ) :699-702.
  • 10Zou H, Chen Y, Duan Z, et al. Protective effect of hepati- tis B vaccine combined with two-dose hepatitis B immu- noglobulin on infants born to HBsAg-positive mothers [ J ]. PLoS One,2011,6 ( 10 ) : e26748.

引证文献4

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部